Author

Alessandra Chesi

Primary ORCID profile (0000-0002-0954-7446 · 26 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Alessandra ChesiiD26 papers · Children's Hospital of Philadelphia

Biology Disciplines

Click to filter author papers

Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Research Focus:protein folding & dynamics· 1

Frequent Co-Authors

Amanda M. GleixneriD· 1 shared Anastasia C. Murthy· 1 shared Ashleigh SmirnoviD· 1 shared Bede PortziD· 1 shared Bo Lim LeeiD· 1 shared Carolann Espy· 1 shared Christopher J. DonnellyiD· 1 shared Cristian A. Bergmann· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Amanda M. GleixnerORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

BiochemistrybioRxivSep 4, 2023

Defining RNA oligonucleotides that reverse deleterious phase transitions of RNA-binding proteins with prion-like domains

Lin Guo, Jacob R. Mann, Jocelyn C. Mauna…·James Shorter

The paper identifies short RNAs that prevent and reverse pathological fibrillization of RNA-binding proteins like FUS and TDP-43, showing therapeutic potential for ALS/FTD.

DOI 10.1016/j.molcel.2025.12.009

humanbulk RNA-seq

𝕏 PostBluesky